Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

A. Castellino, A. Chiappella, B. R. LaPlant, L. D. Pederson, G. Gaidano, W. R. Macon, G. Inghirami, C. B. Reeder, A. Tucci, R. L. King, A. Congiu, J. M. Foran, V. Pavone, C. E. Rivera, M. Spina, S. M. Ansell, F. Cavallo, A. L. Molinari, Giovannino Ciccone, T. M. HabermannT. E. Witzig, U. Vitolo, G. S. Nowakowski

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences